Medicine and HealthCOMMUNICATIONS MEDICINE

Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant

G. R. F. Campos, N. B. F. Almeida, et al.

This groundbreaking study highlights the remarkable effect of a BNT162b2 mRNA vaccine booster dose on antibody neutralization against the SARS-CoV-2 Omicron variant. The research shows a dramatic increase in seroconversion rates from 10% to 76.6% after the booster, showcasing the enhanced immune response facilitated by this combined vaccination strategy. Conducted by a team of experts, this research offers significant insights into vaccine efficacy in combating emerging variants.... show more

General Summary Metrics

Abstract

Background: The emergence of the SARS-CoV-2 Omicron variant, with numerous mutations, raised concerns about vaccine escape, particularly reduced neutralization by vaccine-induced antibodies. Methods: Using viral microneutralization assays, antibody neutralization against Omicron was evaluated in 90 individuals who received a BNT162b2 mRNA booster after a two-dose CoronaVac primary series. Results: Seroconversion 30 and 60 days after the CoronaVac series was 16.6% and 10%, respectively. After the BNT162b2 booster, seroconversion increased to 76.6%, and the mean neutralization titer against Omicron increased 43.1-fold. Conclusions: A BNT162b2 booster following CoronaVac positively impacts the neutralizing antibody response against Omicron.

Publisher

COMMUNICATIONS MEDICINE

Published On

Authors

Guilherme R F Campos, Nathalie Bonatti Franco Almeida, Priscilla Soares Filgueiras, Camila Amorimno Corsini, Sarah Vieira Contin Gomes, Daniel Alvim Pena de Miranda, Jéssica Vieira de Assis, Thaís Bárbara de Souza Silva, Pedro Augusto Alves, Gabriel da Rocha Fernandes, Jaqueline Germano de Oliveira, Paula Raha, Rafaella Fortini Queiroz Grenfell, Maurício L Nogueira

DOI

https://doi.org/10.1038/s43856-022-00141-4

Explore these studies to deepen your understanding

Adjacent work that informs or extends this paper's methodology and findings.

Medicine and Health

Risk factors for and pregnancy outcomes after SARS-CoV-2 in pregnancy according to disease severity: A nationwide cohort study with validation of the SARS-CoV-2 diagnosis of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG)

A. J. M. Aabakke, T. G. Petersen, et al.

Medicine and Health

Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection

M. Patone, L. Handunnetthi, et al.

Medicine and Health

Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2

J. Zou, C. Kurhade, et al.

Medicine and Health

A bispecific nanobody dimer broadly neutralizes SARS-CoV-1 & 2 variants of concern and offers substantial protection against Omicron via low-dose intranasal administration

H. Ma, X. Zhang, et al.

Listen, Learn & Level Up

Over 10,000 hours of research content in 25+ fields, available in 22+ languages.

No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.

listen to research audio papers with researchbunny